Destroying sensory neurons reduced substance P in the spinal cord without changing its receptor, and dopamine blockade increased substance P in the brain without affecting its receptor either.
Independent regulationIn both spinal cord and basal ganglia, substance P levels changed while NK1 receptor mRNA remained constant
What the researchers found
Capsaicin reduced spinal SP and NKA without changing NK1 receptor mRNA. Haloperidol increased basal ganglia SP mRNA without changing NK1 receptor mRNA.
Why it matters
Understanding that the peptide and its receptor are independently controlled means we cannot assume that changing one automatically changes the other. This is important for designing drugs that target the substance P system.
How the study worked
Neonatal rats received capsaicin to destroy sensory neurons. Adult rats received haloperidol for dopaminergic disruption. SP, NKA, SP mRNA, and NK1 receptor mRNA were measured.
What this study cannot tell us
Animal study in rats with pharmacological and chemical manipulations. Results may not apply to all conditions or species. Only mRNA measured for the receptor.
How to read the evidence
Preliminary — animal study using chemical/pharmacological manipulations to test regulatory relationships. Clear results but limited to specific interventions.
When this study was published
Published in 1992 (34 years ago). NK1 receptor antagonists were subsequently developed as drugs for nausea (aprepitant) and depression.
The bigger picture
This finding matters for drug development: you can't assume that blocking substance P production will also reduce its receptor, or vice versa. Each must be targeted separately for effective therapy in pain and movement disorders.
Questions still open
- Are there conditions where the receptor does change in response to peptide levels?
- Does this independent regulation hold true in chronic pain or Parkinson's disease?
Common questions
What is substance P?
Why does independent regulation matter?
Read the original research
Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Journal of neurochemistry, 59(6), 2278-84
Citation
Sivam, S P; Krause, J E. (1992). Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.. Journal of neurochemistry, 59(6), 2278-84.